D. E. Shaw & Co., Inc. Alpine Immune Sciences, Inc. Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$17.75 - $41.6 $2.36 Million - $5.53 Million	133,013 Added 45.01%	428,555 $17 Million
Q4 2023 Feb 14, 2024	BUY	$8.54 - $20.22 $2.11 Million - $4.99 Million	246,911 Added 507.72%	295,542 $5.63 Million
Q3 2023 Nov 14, 2023	BUY	$10.13 - $13.98 $492,632 - $679,861	48,631 New	48,631 $556,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.